We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+18.69%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+505.55%
AUM
$389B
AUM Growth
+$36.3B
Cap. Flow
-$17.4B
Cap. Flow %
-4.48%
Top 10 Hldgs %
19.75%
Holding
5,916
New
643
Increased
1,905
Reduced
2,520
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 14.23%
2 Consumer Discretionary 8.46%
3 Healthcare 7.67%
4 Financials 7.46%
5 Communication Services 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APLS
5376
CALL
DELISTED
Apellis Pharmaceuticals
APLS
-10,000
Closed -$302K
APRE icon
5377
Aprea Therapeutics
APRE
$7.69M
-1,653
Closed -$795K
APT icon
5378
Alpha Pro Tech
APT
$50.1M
-80,420
Closed -$1.19M
ARGX icon
5379
PUT
argenx
ARGX
$54.3B
-5,000
Closed -$1.31M
ARWR icon
5380
PUT
Arrowhead Research
ARWR
$12.3B
-10,000
Closed -$431K
ASHR icon
5381
PUT
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.57B
-13,500
Closed -$465K
ASND icon
5382
CALL
Ascendis Pharma A/S
ASND
$16B
-20,000
Closed -$3.09M
ASND icon
5383
PUT
Ascendis Pharma A/S
ASND
$16B
-20,000
Closed -$3.09M
LONA
5384
LeonaBio Inc
LONA
$72.1M
-17,993
Closed -$3.32M
ATLO icon
5385
AMES National
ATLO
$277M
-17,596
Closed -$297K
ATNI icon
5386
ATN International
ATNI
$369M
-39,911
Closed -$2M
ATOS icon
5387
Atossa Therapeutics
ATOS
$23.8M
-1,420
Closed -$52K
AYTU icon
5388
AYTU BioPharma
AYTU
$24.7M
-116
Closed -$28K
AZN icon
5389
CALL
AstraZeneca
AZN
$250B
-12,550
Closed -$1.38M
BAC.PRL icon
5390
Bank of America Series L
BAC.PRL
$3.99B
-3,021
Closed -$4.5M
BBCP icon
5391
Concrete Pumping Holdings
BBCP
$491M
-13,412
Closed -$48K
BBJP icon
5392
JPMorgan BetaBuilders Japan ETF
BBJP
$18.5B
-27,031
Closed -$1.33M
BBU
5393
DELISTED
Brookfield Business Partners
BBU
-12,461
Closed -$241K
BBY icon
5394
CALL
Best Buy
BBY
$17.8B
-204,600
Closed -$22.8M
BDJ icon
5395
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.74B
-12,996
Closed -$95K
BE icon
5396
PUT
Bloom Energy
BE
$69B
-26,600
Closed -$478K
BILL icon
5397
PUT
BILL Holdings
BILL
$4.81B
-25,000
Closed -$2.51M
BJ icon
5398
PUT
BJs Wholesale Club
BJ
$12.3B
-600,000
Closed -$24.9M
BLRX
5399
BioLineRX
BLRX
$11.8M
-598
Closed -$39K
BNR
5400
Burning Rock Biotech
BNR
$93.7M
-3,394
Closed -$851K

Similar funds

Goldman Sachs's Q4 2020 Portfolio in Review

As of Q4 2020, Goldman Sachs held 5,916 positions worth $389B, up 10% from $352B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Goldman Sachs withdrew a net $17.4B in Q4 2020, closing 466 positions and reducing 2,520 holdings. Its most notable exit was Immunomedics Inc, an estimated $418M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Goldman Sachs opened a new position in Chindata Group Holdings Limited American Depositary Shares worth $290M.

  • Goldman Sachs's largest Q4 2020 buy was Chindata Group Holdings Limited American Depositary Shares: 12,107,899 shares worth $290M.
  • Goldman Sachs added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2020, an estimated $1.04B increase.
  • Goldman Sachs's biggest Q4 2020 reduction was Tesla, cutting an estimated $4.43B.
  • Goldman Sachs fully exited Immunomedics Inc in Q4 2020, selling an estimated $418M.
  • Goldman Sachs's ten largest holdings make up 20% of its $389B portfolio in Q4 2020.
  • Goldman Sachs opened 643 new positions and closed 466 in Q4 2020.
  • Goldman Sachs's portfolio value rose 10% quarter-over-quarter to $389B.

Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.